Breaking News Bar

Business News and Information

Recent Quotes
My Watchlist
Indicators
Local Stocks
The Daily Herald Market Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Axovant Sciences Ltd (NQ: AXON )

1.220 USD UNCHANGED
Last Price Updated: 6:35 PM EST, Feb 13, 2019 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 1.220
Bid (Size) 1.230 (4)
Ask (Size) 1.240 (14)
Prev. Close 1.220
Today's Range 1.220 - 1.220
52wk Range N/A - N/A
Shares Outstanding 107,788,074
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Axovant Announces Formation of Arvelle Therapeutics and Strategic Transition of Legacy Small Molecule Team Into Newly Formed Company
Axovant Sciences (NASDAQ: AXGT), a clinical-stage company developing innovative gene therapies, today announces the formation of Arvelle Therapeutics and the strategic transition of its legacy small... 
From GlobeNewswire News Releases
Axovant Announces Third Fiscal Quarter 2018 Financial Results and Corporate Updates
Axovant Sciences (NASDAQ: AXON), a clinical-stage company developing innovative gene therapies, today provided financial results and corporate updates for its third fiscal quarter and nine months ended... 
From GlobeNewswire News Releases

Performance

More News

Read More
Axovant Announces Presentation at J.P. Morgan Healthcare Conference and Anticipated 2019 Clinical Development Milestones
From GlobeNewswire News Releases
Roivant Sciences to Present at the 37th Annual J.P. Morgan Healthcare Conference
From PR Newswire
Detailed Research: Economic Perspectives on Canopy Growth, ArQule, MoneyGram International, Teradata, Clovis Oncology, and Axovant Sciences — What Drives Growth in Today's Competitive Landscape
From GlobeNewswire News Releases
Hercules Capital Announces Multiple Outstanding Achievements by Numerous Investment Portfolio Companies
From Business Wire News Releases
Roivant Sciences and Daiichi Sankyo Enter into Broad Pipeline Partnership
From PR Newswire
Axovant Sciences Announces Pricing of $30 Million Public Offering of Common Shares
From GlobeNewswire News Releases
Axovant Sciences Announces Public Offering of Common Shares
From GlobeNewswire News Releases
Axovant Licenses Investigational Gene Therapies for GM1 Gangliosidosis, Tay-Sachs and Sandhoff Diseases from University of Massachusetts Medical School
From GlobeNewswire News Releases
Here's Why Axovant Gene Therapies Rocketed Higher Today
Tags AXON Market News
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
bottom clear
Search DailyHerald.com for articles
More ways to search Daily Herald
Obituaries
Search DailyHerald.com obituaries. » Daily Herald newspaper archive
Find archived newspaper articles back to 1901. »
Digital Subscriptions
Activate Subscriber Access Purchase a Digital Subscription
Home Delivery
Start a New Subscription Manage Account